• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Singleplex qPCR Assay Outperforms Culture in Detecting Mastitis Corynebacterium Pathogens

by
November 13, 2026
in Health
Reading Time: 6 mins read
0
Singleplex qPCR Assay Outperforms Culture in Detecting Mastitis Corynebacterium Pathogens

Singleplex qPCR Assay Outperforms Culture in Detecting Mastitis Corynebacterium Pathogens

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A newly established multi-tube singleplex quantitative polymerase chain reaction assay has markedly improved the microbiological detection of bacterial pathogens in pus specimens from patients suffering from granulomatous mastitis. Evaluating eighty-six clinical pus samples, the molecular platform achieved detection proportions that exceeded those obtained through an optimized microbial culture protocol by 10.4 percentage points for the Corynebacterium kroppenstedtii complex and by 34.9 percentage points for the wider Corynebacterium genus. In total, the assay identified genus-level Corynebacterium sequences in 72.1 percent of clinical specimens and established the presence of the Corynebacterium kroppenstedtii complex in 43.0 percent. Conducted across clinical and academic medical centers in Chengdu, China, the research targeted longstanding diagnostic bottlenecks where fastidious, slow-growing bacteria frequently evade conventional microbiological recovery. By combining genus-specific, complex-specific, and broad-range bacterial targets alongside a host reference gene, the diagnostic framework unmasks bacterial involvement that often remains undetected during routine laboratory examinations.

Granulomatous mastitis represents an intractable, chronic non-caseating granulomatous inflammatory disorder of the breast parenchyma that causes severe physical distress and displays a pronounced tendency to recur. Pathologically, the clinical disease course typically evolves through distinct anatomical stages, commencing as a firm inflammatory mass, developing into localized abscesses, and ultimately forming chronic draining sinuses or persistent fistulas. Although debates persist regarding whether autoimmune mechanisms or bacterial infections predominate, clinical evidence increasingly recognizes the Corynebacterium kroppenstedtii complex as the primary microbiological agent driving pathology. Purulent exudates collected during the abscess stage provide the most reliable diagnostic substrate, as prior studies demonstrated that Corynebacterium detection in pus is substantially higher than in core needle biopsies, with over seventy-seven percent of positive cases identified exclusively from pus samples. Accurately distinguishing the etiology of granulomatous mastitis is essential for guiding treatment.

Despite the recognized clinical relevance of bacterial pathogens in granulomatous mastitis, laboratory confirmation has been severely hampered by the fastidious growth of Corynebacterium species. Microorganisms within the Corynebacterium kroppenstedtii complex are strictly lipophilic and replicate exceedingly slowly, creating substantial barriers to conventional isolation. Following seventy-two hours of incubation on standard blood agar plates, these organisms form only pinpoint colonies, resulting in clinical culture recovery rates between 4.7 percent and 16.0 percent. Furthermore, published studies document missed detection rates on routine blood agar plates as high as 90.0 percent and 98.9 percent. Although optimized lipid-supplemented media and sealed incubation techniques have improved recovery, culture remains time-consuming and vulnerable to failure when bacterial titers are low. While matrix-assisted laser desorption/ionization time-of-flight mass spectrometry enables rapid identification, it remains strictly dependent on first obtaining viable cultured colonies.

Earlier diagnostic attempts employing quantitative PCR in granulomatous mastitis were constrained by focusing exclusively on Corynebacterium kroppenstedtii as an individual species. That approach overlooked the genetic breadth of the Corynebacterium kroppenstedtii complex and missed closely related non-complex Corynebacterium species increasingly implicated in clinical breast infections. To establish comprehensive diagnostic coverage, the research team designed a multi-tube singleplex quantitative PCR system targeting sequences from 16S ribosomal RNA, rpoB, and fusA genes. Phylogenetic analyses constructed using the neighbor-joining method in MEGA 11 and multiple alignments in DNAMAN V6.0 demonstrated that the genus Corynebacterium forms a well-defined clade in 16S ribosomal RNA and fusA trees, while the Corynebacterium kroppenstedtii complex exhibits maximal genetic divergence in the rpoB tree. Therefore, rpoB was prioritized for complex-specific primer design, while 16S ribosomal RNA and fusA were selected for genus-specific assays conforming to standard quantitative PCR reporting criteria.

The screening workflow evaluated twenty newly designed primer pairs alongside ten literature-derived universal bacterial pairs and a human host control marker. Following Primer-BLAST screening, candidate oligonucleotides underwent rigorous in vitro specificity validation against twenty bacterial strains, encompassing seven Corynebacterium kroppenstedtii complex strains, six non-complex Corynebacterium strains, and seven unrelated organisms. Among complex-specific candidates, the primer pair rpoB-703F/rpoB-989R, producing a 287-base-pair amplicon, achieved optimal analytical performance with a mean quantification cycle of 22.15 ± 0.15 and an inter-run coefficient of variation of 0.7 percent. For genus-level detection, the 16S-431F/16S-563R pair, generating a 154-base-pair amplicon, demonstrated superior efficiency, with a mean quantification cycle of 21.50 ± 0.20 and a coefficient of variation of 0.9 percent, reliably amplifying all thirteen tested Corynebacterium strains without amplifying non-corynebacterial organisms or negative controls.

To provide pan-bacterial surveillance, the researchers evaluated ten candidate universal 16S ribosomal RNA primer pairs, selecting the 357F/518R pair generating a 177-base-pair amplicon. Universal bacterial quantitative PCR assays universally exhibit non-specific background amplification in no-template controls due to environmental bacterial DNA fragments, and the 357F/518R assay demonstrated background amplification at quantification cycles around 28.2 to 28.3. Amplification efficiency for this marker was 113.4 percent to 113.6 percent, with melting curve analysis confirming a unimodal dissociation peak at 87.08 ± 0.21 degrees Celsius. To confirm pus specimen adequacy and verify human cellular extraction, human beta-actin primers were incorporated as an internal reference. Across all eighty-six pus specimens, beta-actin amplification was positive, exhibiting quantification cycles from 17.03 to 26.69 with a mean of 20.78 ± 2.32. The mean cycle separation between specimens and no-template controls was 14.20 ± 2.31, satisfying quality criteria requiring a separation of at least five cycles.

Analytical performance parameters and standard calibration curves were constructed using serial dilutions of genomic DNA extracts and crude heat-lysis supernatants from Corynebacterium kroppenstedtii strain LCNY-20 across nine technical replicates. Linear regression models confirmed strong linearity across both template preparations. For purified genomic DNA, regression equations and coefficients of determination were y = −3.4408x + 51.969 with R² = 0.9988 for the complex-specific assay, y = −3.3384x + 49.392 with R² = 0.9958 for the genus-specific assay, and y = −3.034x + 45.928 with R² = 0.9944 for the universal assay. In heat-lysis supernatants, corresponding coefficients were 0.9955, 0.9909, and 0.9998, respectively. Melting curves produced sharp dissociation peaks at 88.22 ± 0.09 degrees Celsius for the complex-specific assay and 85.44 ± 0.13 degrees Celsius for the genus-specific assay. The analytical limit of detection for both targeted primer sets was established at 1×10⁴ colony-forming units per milliliter.

The clinical evaluation encompassed eighty-six consecutively collected pus specimens obtained from patients with imaging- and pathology-confirmed granulomatous mastitis undergoing initial surgical drainage across two hospital centers during 2025. Specimen preparation was streamlined for clinical applicability, requiring two minutes of vortex-mixing, ten minutes of thermal lysis at one hundred degrees Celsius, centrifugation, and direct introduction of the supernatant into the reaction master mix. Testing all specimens in triplicate alongside controls demonstrated that the genus-specific assay was positive in sixty-two specimens, representing a 72.1 percent detection proportion with quantification cycles spanning 20.74 to 38.15. The complex-specific assay was positive in thirty-seven specimens, establishing a 43.0 percent detection proportion with quantification cycles from 26.20 to 39.78. Amplicons from every positive clinical specimen underwent Sanger sequencing, and sequence alignment corroborated the presence of corresponding target-specific Corynebacterium and complex-related sequences, verifying amplification fidelity directly from clinical pus.

Parallel microbiological isolation using an optimized culture method recovered viable bacterial pathogens in forty-five of the eighty-six clinical specimens, corresponding to an overall culture yield of 52.3 percent. Culturing recovered Corynebacterium kroppenstedtii complex isolates in twenty-eight specimens (32.6 percent), non-complex Corynebacterium in four specimens (4.7 percent), and non-Corynebacterium organisms in thirteen specimens (15.1 percent). Comparative statistical analysis using the exact McNemar test demonstrated that the complex-specific quantitative PCR achieved a detection proportion 10.4 percentage points higher than optimized culture (43.0 percent versus 32.6 percent; 95 percent confidence interval, 4.0 to 16.8; P = 0.0039). The genus-specific assay exceeded optimized culture recovery by 34.9 percentage points (72.1 percent versus 37.2 percent; 95 percent confidence interval, 24.3 to 44.0; P < 0.001). Furthermore, quantification cycles in culture-negative specimens were significantly higher than in culture-positive specimens for both complex-specific (36.81 ± 2.77 versus 32.28 ± 2.95; P = 0.003) and genus-specific assays (34.74 ± 1.83 versus 30.17 ± 3.28; P < 0.001).

Because universal 16S ribosomal RNA primers generated amplification across all specimens and controls, researchers established an exploratory diagnostic threshold using receiver operating characteristic curve analysis. Stratifying the eighty-six specimens into sixty-seven reference-positive and nineteen reference-negative samples yielded an area under the curve of 0.887 (standard error = 0.045; 95 percent confidence interval, 0.799 to 0.975; P < 0.001). The optimal cycle threshold cut-off was 22.43, providing a sensitivity of 74.6 percent and specificity of 89.5 percent. In a retrospective cohort of sixty-nine patients, cases were classified into four groups: complex detected (thirty-one cases), non-complex Corynebacterium detected (eighteen cases), other bacteria detected (five cases), and no bacteria detected (fifteen cases). Comparisons across these four cohorts revealed no statistically significant differences in patient age, median lesion diameter, treatment duration, hospitalizations, sinus or fistula rates, hyperprolactinemia, or antibiotic usage (all P > 0.05), confirming that clinical presentation alone cannot differentiate underlying etiology.

Evaluating empirical antibiotic therapy among forty-nine patients with confirmed Corynebacterium involvement revealed no statistically significant associations with clinical outcomes, showing comparable treatment duration (median: 197 versus 188 days; P = 0.886), hospital admissions (median: 2 versus 2; P = 0.864), and fistula formation (65.7 percent versus 57.1 percent; odds ratio = 1.44; 95 percent confidence interval, 0.40 to 5.11; P = 0.744). Levofloxacin was the most commonly administered antibiotic, prescribed in 44.9 percent of cases, despite reported fluoroquinolone resistance among Chinese Corynebacterium kroppenstedtii isolates reaching 67.8 percent. The authors highlighted limitations, including validation on a limited number of bacterial strains, potential incorporation bias in the single-cohort cycle threshold cut-off, reliance on drainable pus, and small subgroup sizes.

Subject of Research: Molecular detection of Corynebacterium species in granulomatous mastitis pus

Article Title: A multi-tube singleplex qPCR assay for detection of the Corynebacterium kroppenstedtii complex, Corynebacterium spp., and other bacteria in granulomatous mastitis

Article References: Chen, K., Yuan, Y., Liu, F., Tang, N., Yang, W., Chen, C., Xie, X., Chen, J., Huang, W., Liu, F., Peng, C., & Pan, Q. (2026). A multi-tube singleplex qPCR assay for detection of the Corynebacterium kroppenstedtii complex, Corynebacterium spp., and other bacteria in granulomatous mastitis. Frontiers in Cellular and Infection Microbiology, 16, Article 1916910. https://doi.org/10.3389/fcimb.2026.1916910

Image Credits: AI Generated

DOI: 10.3389/fcimb.2026.1916910

Keywords: granulomatous mastitis, Corynebacterium kroppenstedtii complex, Corynebacterium genus, quantitative PCR, singleplex qPCR, pus specimens, rpoB gene, 16S rRNA, fusA gene, beta-actin reference, bacterial detection rate, optimized culture method, limit of detection, receiver operating characteristic, cycle threshold cut-off, empirical antibiotic therapy, levofloxacin resistance

News Source: Ophelia Keating. (November 13, 2026). Singleplex qPCR Assay Outperforms Culture in Detecting Mastitis Corynebacterium Pathogens. Scienmag.

Tags: 16S rRNAbacterial detection ratebeta-actin referenceCorynebacterium genusCorynebacterium kroppenstedtii complexcycle threshold cut-offempirical antibiotic therapyfusA genegranulomatous mastitislevofloxacin resistancelimit of detectionoptimized culture methodpus specimensquantitative PCRreceiver operating characteristicrpoB genesingleplex qPCR
Share12Tweet7Share2ShareShareShare1

Related Posts

Five Clinical Factors Predict Diabetic Retinopathy Risk in Type 2 Diabetes

Five Clinical Factors Predict Diabetic Retinopathy Risk in Type 2 Diabetes

November 17, 2026
Abdominal CT Radiomics Identifies Prevalent Heart Disease in Type 2 Diabetes

Abdominal CT Radiomics Identifies Prevalent Heart Disease in Type 2 Diabetes

November 17, 2026

Researchers Propose D-Allulose Framework to Test Metabolic Signaling and Aging

November 17, 2026

Gut Microbiome Shifts Linked to Depressive Symptoms in Diabetes Patients

November 17, 2026

POPULAR NEWS

  • Five Clinical Factors Predict Diabetic Retinopathy Risk in Type 2 Diabetes

    Five Clinical Factors Predict Diabetic Retinopathy Risk in Type 2 Diabetes

    29 shares
    Share 12 Tweet 7
  • Abdominal CT Radiomics Identifies Prevalent Heart Disease in Type 2 Diabetes

    29 shares
    Share 12 Tweet 7
  • Researchers Propose D-Allulose Framework to Test Metabolic Signaling and Aging

    29 shares
    Share 12 Tweet 7
  • Gut Microbiome Shifts Linked to Depressive Symptoms in Diabetes Patients

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Five Clinical Factors Predict Diabetic Retinopathy Risk in Type 2 Diabetes

Abdominal CT Radiomics Identifies Prevalent Heart Disease in Type 2 Diabetes

Researchers Propose D-Allulose Framework to Test Metabolic Signaling and Aging

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.